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Abstract
Direct reprogramming which changes the fate of matured cell is a very useful technique with a great interest
recently. This approach can eliminate the drawbacks of direct usage of stem cells and allow the patient specific
treatment in regenerative medicine. Overexpression of diverse factors such as general reprogramming factors or
lineage specific transcription factors can change the fate of already differentiated cells. On the other hand,
biomaterials can provide physical and topographical cues or biochemical cues on cells, which can dictate or
significantly affect the differentiation of stem cells. The role of biomaterials on direct reprogramming has not been
elucidated much, but will be potentially significant to improve the efficiency or specificity of direct reprogramming.
In this review, the strategies for general direct reprogramming and biomaterials-guided stem cell differentiation are
summarized with the addition of the up-to-date progress on biomaterials for direct reprogramming.
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Background
Regenerative medicine has been getting the spotlight in
the medical science as a solution of intractable diseases.
Especially stem cell therapy has great potential to cure
many injuries and diseases. Stem cells have the ability to
continuously divide and differentiate into various kinds
of cells or tissues [1]. The main types of stem cells are
embryonic stem cell (ESC), adult stem cell (ASC), and
induced pluripotent stem cell (iPSC). ESC is derived
from the inner cell mass of a blastocyst. It has pluripo-
tency to be expanded unlimitedly and can differentiate
to all three germ layers. But it is hard to get ESC and
furthermore there is a severe ethical issue [2]. On the
other hand, ASC, also called somatic stem cell, comes
from the body after embryonic development, such as
bone marrow, umbilical cord, adipose tissue, and blood
cell. The source of ASC is more affordable than ESC,
and ASC have less ethical issues compared to ESC [3, 4].
However, ASC is multipotent, not pluripotent, so the
differentiation ability is less than ESC [5]. For overcoming
the limitation of ESC and ASC, iPSC has been developed.
iPSC is reprogrammed human cell by some defined
factors to generate the patient-specific pluripotent cell
lines [6, 7]. Yamanaka showed that iPSC can be generated
using only four transcription factors, Oct4, Sox2, Klf4, and
c-Myc [7]. iPSC can be obtained easily and has pluripo-
tency to differentiate into any one of three germ layers,
meaning that iPSC is a powerful regenerative medicine
tool right away. However, iPSC also has several obstacles
for practical applications. First of all, iPSC is not safe for
clinical applications in its current state [8, 9]. Commonly,
viral vector systems are used to generate iPSC, which
might integrate into the host DNAs. More importantly,
iPSC has risk to form tumors when transplanted in vivo
because of the use of oncogene in the reprogramming
process. Also, the efficiency of generating iPSC has been
too low yet.
Direct reprogramming is a new approach to overcome
diverse problems of stem cell therapies. Direct repro-
gramming means that reprogramming the somatic cell
into a desired patient specific cell directly without pass-
ing through the pluripotent stem cell stage [10]. This
method has a low risk about epigenetic remodeling and
tumor formation. Also, it is more efficient and can be
accomplished in an economy of time. In this review,
direct reprogramming into various cell lineages will be
introduced. Also biomaterials for affecting stem cell
differentiation will be presented, and finally biomaterials
to increase the efficiency of direct reprogramming will
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be introduced. Generally, direct reprogramming is also
called transdifferentiation. Direct reprogramming and
transdifferentiation are usually used as the same meaning,
but exactly, direct reprogramming means the changing
fate of somatic cell without dedifferentiation process and
transdifferentiation means that less differentiated cell of
certain lineage differentiates into other cell of similar
lineage [11]. Here, the term ‘direct reprogramming’ will be
used as the same meaning with transdifferentiation.
Direct reprogramming
The general strategy for direct reprogramming uses
transcription factors depending on the lineage of target.
Most common cell source is the fibroblast from mouse
or human. Here, recent examples of direct reprogram-
ming will be discussed according to the final target cell
type: Neural cells, cardiomyocytes and hepatocytes.
Direct reprogramming to neural cells
Neurodegenerative disorders, such as Alzheimers disease,
Parkinsons’s disease and Huntingtons’ disease, have high
lethality but there is no obvious cause and no effective
medical treatment. Common symptoms of neurodegener-
ative disorders are continuously dying neural cells through
necrosis or apoptosis, so cell regeneration of neural cells
are necessary to cure those diseases. Thus, direct repro-
gramming approach can provide powerful regenerative
therapies for neurodegenerative disorders [12].
A progenitor cell is undifferentiated state into mature
functional cell, so it can differentiate into some types of
mature cell but not all types of cell because it is not a
stem cell. Different from direct reprogrammed neurons,
direct reprogrammed neural progenitors can expand in
vitro and possess the ability to differentiate into multiple
neuronal subtypes. Mouse embryonic fibroblast can be
reprogrammed to diverse neural progenitor cells. First,
induced neural progenitor cells (iNPCs) are generated
using forced expression of Yamanaka factors (Oct4,
Sox2, Klf4, c-Myc) [13]. Although using the same
factors which made iPSC, this group manipulated the
specific signals affecting cell fates. This research also pro-
vided the possibilities of various applications with subtle
signal changing because they used general reprogramming
factors, not lineage specific transcription factors. Func-
tional midbrain dopaminergic induced neuronal progeni-
tors (iDPs) could be reprogrammed from mouse
embryonic fibroblast or adult tail-tip fibroblast using 4
Yamanaka factors, Shh, and FGF8 [14]. Morphogen for
midbrain development promoted the reprogramming and
inhibiting JAK-STAT pathway which enhanced the effi-
ciency of the reprogramming process. Induced oligo-
dendrocyte precursor cells (iOPCs) were generated from
mouse and rat fibroblast using transcription factors
Sox10, Olig2, Zfp536 [15]. iOPCs could differentiate into
astrocytes and myelinating oligodendrocytes. Although
the differentiation efficiency of iOPCs was lower than that
of neonatal OPCs, iOPCs are valuable because primary
human tissues are limited. There are similar researches
using human fibroblast. S Andrew et al. [16] made human
induced neural progenitor cells (hiNPs) with miR-9/9,
miR-124, and Neurod2 from human neonatal foreskin and
adult dermal fibroblast. Micro RNAs, miR-9/8, and miR-
124 regulated the neuronal differentiation and SWI/SNF-
like BAF chromatin-remodeling complex, important for
neuronal function, so they could control the neuronal fate.
Additional Ascl1 and Myt1l increased the reprogramming
efficiency. C Maucksch et al. [17] also generated hiNPs
from adult dermal fibroblast using Sox2, Pax6, and
recombinant protein transduction. Shh helped the
regulation of neuronal differentiation from iNPs into
functional and fully matured neurons. Overall, it took
less time to convert neural precursor cells to functional
neurons than iPSCs. However, iNPs required additional
steps for redifferentiation into functional neurons unlike
induced neurons. And, the multipotency of iNPs can be a
strength but also be a weakness because the higher multi-
potency might have a risk going to pluripotency stage than
functional cell, and a lower efficiency to be mature cell.
There also exist some known transcription factors
which are specifically dominant in functional neurons,
but not progenitor cells. Recent researches showed the
overexpression of these transcription factors can induce
the specific functional cell types. Direct reprogramming
with neural-specific transcription factors could do inter-
lineage reprogramming not only fate switching within
the major lineage. Vierbuchen et al. [18] cloned 19 genes
that are definitely expressed in neural tissues for screen-
ing the neural fate inducing factors. They found the
three gene combination of Ascl1, Brn2 and Myt1l. The
genes were sufficient to reprogram mouse embryonic
dermal and postnatal tail-tip fibroblast into induced neu-
rons (iNs). Although Ascl1 alone could induce neural
functions like action potential, but coinfection of Brn2
and Myt1l was necessary for neural conversion and mat-
uration. Similarly, the same three gene combination has
been used in other groups [19–21]. To solve the prob-
lem of heterogeneous population of iNs, other re-
searchers used lineage-specific factors for generating
functional neurons. One group changed mouse embry-
onic and adult tail-tip fibroblast into induced motor
neurons (iMNs) with Ascl, Brn2, Myt1l, Lhx3, Hb9, Isl1,
and Ngn2. Addition of motor neuron specific factors to
basic neural fate inducing factors efficiently induced
motor neurons [22]. iMNs present motor neuron char-
acteristics such as electrophysiological actor or forming
functional synapses with muscle. Ectopic expression of
Ascl1, Nurr1, Lmx1a could change mouse prenatal and
adult tail-tip fibroblast to induced dopaminergic neurons
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(iDAs) [23]. This genetic reprogramming removed the
major gene expression of the original cells, and
expressed the induced target cell related gene. The
strengths of this iDAs are rapid processing and mainten-
ance. The reprogramming was achieved only in 6 days
after expression of the factors and it remained a stable
neuronal state over time.
There are other reports using human fibroblast. Human
fetal limb and postnatal foreskin were changed to human
induced neurons (hiNs) using Ascl1, Brn2, Myt1l and
NeuroD1 factors [24]. Without NeuroD1, basic helix-
loop-helix transcription factor, hiNs became functionally
immature. Compared to mouse iNs, hiNs needed a long
time to develop the synaptic activities. Instead of Ascl1,
miR-124 with Myt1l and Brn2 also could generate hiN
from human adult dermal fibroblasts [25]. miR-124 is a
microRNA, most abundant in the mammalian CNS and
upregulated in neurons. miR-124 helped the reprogram-
ming to neurons by inhibiting the nonneuronal gene
expression post transcriptionally. Human induced motor
neurons (hiMNs) could be generated with the combin-
ation of Ascl1, Brn2, Myt1l, Lhx3, Hb9, Isl1, Ngn2, and
Neurod1 [22]. Also human induced dopaminergic neu-
rons (hiDAs) from human prenatal lung and adult skin
cell could be generated by Ascl1, Nurr1, and Lmx1a [23].
The other combination for hiDAs is Mash1, Ngn2, Sox2,
Nurr1, and Pitx3. Using this combination, human fetal
lung fibroblast changed into hiDAs [26]. Exogenous
expression of the five transcription factors significantly in-
fluenced on their endogenous counterparts. When hiDAs
were injected into the rat model of Parkinson’s disease,
the rotational behavior was stabilized distinctly. Also in
vivo transplanted hiDAs are less likely to form tumors, al-
though lentiviral vector may have integrated into the gen-
ome and block tumor suppressor genes.
Direct reprogramming does not rely on pluripotent
stage, which is prone to tumors in their undifferentiated
state. So, it can overcome the weakness of stem cell ther-
apies. Also the source for direct reprogramming is suffi-
cient in humans including patients’ themselves. Therefore,
direct reprogramming is very promising for neurodegen-
erative diseases (Table 1).
Direct reprogramming to cardiomyocytes
Heart disease is caused by not only atherosclerosis and
hypertension but also daily eating and life habits, so it
usually occurs more in older ages [27]. But, there is also
a congenital heart malformation due to the improper de-
velopment of cardiomyocytes during embryogenesis. If
heart disease occurs, the treatment is not easy because
the postnatal cardiomyocytes do not have regenerative
capacity. So, there exist many articles regarding stem cell
Table 1 Direct reprogramming into neural cells
Species Starting cells Target cells Reprogramming factors Gene delivery Efficiency (%) Reference
Mouse Fibroblast embryonic, adult
(tail-tip)
iNPC Oct4, Sox2, Klf4, c-Myc Lentivirus 0.7 [13]
Mouse Fibroblast embryonic iDP Oct4, Sox2, Klf4, c-Myc, SHH, FGF8 Lentivirus 26 [14]
Mouse Fibroblast embryonic iOPC Sox10, Olig2, Zfp536 Lentivirus 25 [15]
Human Fibroblast neonatal (skin),
adult (dermal)
hiNP NeuD2, MiR-9, 124, Ascl1, Myt1l Lentivirus 5 [16]
Human Fibroblast adult (dermal) hiNP Sox2, Pax6 Nonviral plasmid or
Recombinant protein
0.05 [17]
Mouse Fibroblast embryonic, postnatal
(tail-tip)
iN Ascl1, Brn2, Myt1l Lentivirus 19.5 [18]
Mouse Fibroblast embryonic iN Brn2, Ascl1, Myt1l pmax vector 7.6 [19]
Mouse Fibroblast embryonic iN Ascl1, Brn2, Myt1l Lentivirus 11.6~16.1 [20]
Mouse Fibroblast embryonic, adult
(tail-tip)
iMN Ascl1, Brn2, Mytl1, Lhx3, Hb9, Isl1, Ngn2 Retrovirus 5~10 [22]
Mouse Fibroblast prenatal, adult
(tail-tip)
iDA Ascl1, Nurr1, Lmx1a Lentivirus 18 [23]
Human Fibroblast fetal (limb),
postnatal (skin)
hiN Brn2, Ascl1, Myt1l, NeuroD1 Lentivirus 17~21 [24]
Human Fibroblast adult (dermal) hiN MiR-124, Myt1l, Brn2 Lentivirus 1.5~2.9 [25]
Human Fibroblast embryonic iMN Ascl1, Brn2, Mytl1, Lhx3, Hb9, Isl1,
Ngn2, NeuroD1
Retrovirus - [22]
Human Fibroblast prenatal (lung),
adult (skin)
hiDA Ascl1, Nurr1, Lmx1a Lentivirus 3~6 [23]
Human Fibroblast fetal (lung) hiDA Mash1, Ngn2, Sox2, Nurr1, Pitx3 Lentivirus 1~2 [26]
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based heart disease therapies. However, stem cell-
derived cardiomyocytes have many problems such as
functional heterogeneity, maturity, potential tumorigen-
icity, low survival, retention of delivered cells, and insuf-
ficient stem cell source [28]. Direct reprogramming
could provide better solution. The heart is composed of
cardiomyocytes, vascular cells, and cardiac fibroblasts.
Among them, cardiac fibroblasts occupy over 50% [29].
Cardiac fibroblasts support the cardiac structure, secrete
signals and form scar formation upon cardiac damages.
Direct reprogramming from cardiac fibroblasts to cardi-
omyocytes have been tried.
M Ieda et al. [30] induced cardiomyocyte-like cells
(iCMs) from mouse neonatal cardiac and tail-tip dermal
fibroblasts. They used three developmental cardiac tran-
scription factors, Gata4, Mef2c, and Tbx5. This combin-
ation generated iCMs rapidly and efficiently within 7 days
after transduction although full maturation required more
times. iCMs showed spontaneous contraction activity.
But, they indicated that the oscillation frequency of tail-tip
fibroblast derived iCMs was lower than that of cardiac
fibroblast derived iCMs. The other group used the same
Gata4, Mef2c, and Tbx5 factors, but mouse adult cardiac
fibroblast was used as starting cells [31]. They confirmed
the reprogrammed hearts showing good sarcromere for-
mation and contractile potential. Also iCMs could couple
with viable endogenous cardiomyocytes electrically. In
vivo test showed iCMs injected mouse had functional im-
provement for all parameters. Additional Thymosin β4
with the combination improved cardiac function and de-
creased scar size in vivo. K song et al. [32] reprogrammed
mouse adult cardiac and tail-tip fibroblast into iCMs using
Gata4, Mef2c, Tbx5, and Hand2. Previous researches
showed the efficiency of reprogramming using adult fibro-
blast was lower than using neonatal fibroblast. But this
group improved the efficiency up to the quadruple using
additional Hand2. It was a very valuable result because
cardiac fibroblast is the most prevalent cell type in adult
hearts. iCMs of this group showed a similar calcium tran-
sient pattern to neonatal ventricular cardiomyocytes than
adults and it could couple with surrounding myocytes
through gap junction. The heart post myocardial infarc-
tion reduction was also confirmed in vivo. There have
been some researches using mouse embryonic fibroblast.
One group reprogrammed iCMs from mouse embryo
mesoderm using Gata4, Tbx5, and Baf60c [33]. Baf50c
with Gata4 could initiate the ectopic cardiac gene expres-
sion. Another group, who started reprogramming from
embryonic fibroblast, interestingly used Yamanaka factors.
Ectopic expression of Oct4, Sox2, Klf4, and c-Myc could
make cardiomyocytes [34]. In spite of using the same
factors, they grew cells in feeder cell with LIF-removed
cardioinductive media. Then, early cardiac programmed
cell was made. Of course, an early cardiac programmed
cell needs cytokine and chemically defined media for ter-
minal differentiation. It takes 3 weeks to make iPSC using
Yamanaka factor, but it took only 12 days for direct repro-
gramming to cardiomyocyte using Yamanaka factor. An-
other promising alternative strategy is using microRNA.
Jayawardena et al. [35] induced iCMs from mouse neo-
natal and adult cardiac fibroblast using a combination
of miRNAs, mirR-1, 133, 208, and 499. Small size single
miRNA can target multiple gene expression pathways
simultaneously. Using miRNAs increased the repro-
gramming efficiency and homogeneity of resulting cells
because miRNA could pack multiple transcripts in the
same delivery vectors.
There are some researches using human fibroblasts to
make cardiomyocytes. One group induced cardiomyo-
cytes (hiCMs) from human fetal heart and neonatal skin
fibroblast by using Gata4, Mef2c, Tbx5, Essrg, and
Mesp1 [36]. Additional Myocardin and Zfpm2 enhanced
the reprogram efficiency, sacromere formation, calcium
transients, and action potential. And, hiCMs reprogram-
ming efficiency could be improved by TGF-β signaling.
Other research used miRNAs for hiCMs. They made
hiCMs from human neonatal foreskin and adult cardiac,
dermal fibroblast with Gata4, Hand2, Tbx5, myocardin,
miR-1, and miR-133 [37]. Cardiac transcription factors
were used equally with mouse cells, but human cells
were more resistant to the artificial processing. More-
over, adult had more stable epigenetic programs and
resistance than neonatal. Therefore, additional regula-
tory factors were necessary and so they chose miRNAs.
In summary, for inducing cardiomyocytes from fibro-
blast, cardiac transcription factors are needed. Among
them, the main factors are Gata4, Tbx5, and Mef2c.
Gata4 binds to its target site in the genome, so it plays
as a pioneer. Tbx5 is essential for heart beating function.
Mef2c is important in cardiac morphogenesis and myo-
genesis [38]. Further study is necessary for clinical appli-
cation because hiCMs are still functionally immature
and reprogramming efficiency varies. However, it is a
very attractive strategy for curing both congenital and
acquired heart diseases and improving the quality of life.
Direct reprogramming to hepatocytes
Hepatocyte is a main cell type in the liver. The liver
regulates lots of physiological processes in our body.
Liver diseases, such as liver metabolic diseases or acute
liver failure, are very severe death causing problems [39].
For the treatment of liver diseases, liver transplantation
is the golden standard. But, due to the limited supply of
liver donation, hepatocytes transplantation can be an
alternative.
Sekiya et al. [40] screened hepatic fate inducing factors
and found that Hnf4a, Foxa1, Foxa2, or Foxa3 can repro-
gram mouse fibroblast into hepatocyte-like cells (iHeps).
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Foxa2 was used for embryonic fibroblast, and Foxa3 was
used for adult dermal skin fibroblast. The characteristics
of iHeps such as gene expression or morphology and
hepatic functions are similar to that of mature hepato-
cytes. When iHeps were transplanted into the mouse liver,
they could repair hepatic defects. Another method for
inducing functional iHeps is an ectopic expression of
Gata4, Hnf1a, Foxa3, and inactivation of p19Arf [41]. This
combination could make iHeps from mouse adult tail-tip
fibroblast. Gata4 and Foxa3 acted as chromatin modifica-
tion, and then Hnf1a stabilized the induced hepatic gene
expression. p19Arf is an important component of the
cellular senescence pathway and it inhibits iPSC repro-
gramming. So the inhibition of p19Arf could overcome
the proliferative limitation.
Recently, the similar researches using human cell were
studied. Huang et al. [42] generated human induced
hepatocytes (hiHeps) from human fetal limb and adult
dermal fibroblast with expression of Foxa3, Hnf1a, and
Hnf4a. This hiHeps had mature hepatic functions like
biliary excretion of drug compound or CYP enzyme
activities. Compared to fetal limb derived hiHeps, adult
dermal derived hiHeps showed a low hepatic conversion
rate. Another group used human newborn fibroblast to
make hiHeps with Oct4, Sox2, and Klf in medium con-
taining established growth factors and small molecule
CHIR [43]. The factors they used are some of Yamanaka
factors, but it did not undergo the pluripotent state.
Strictly speaking, it is not a definite direct reprogramming
strategy because they induced multipotent progenitor
(iMPC) and then redifferentiated into hepatocytes.
Overall, the engraftment efficiency of iHeps does not
reach to that of adult hepatocytes and it takes a long
time for post-transplant maturation. The level of direct
reprogramming to hepatocytes is not suitable for clinical
application yet. However, patient derived hiHeps could
be used in regenerative medicine and disease modeling
in liver diseases in near future [44] (Table 2).
Biomaterials strategies for effective cell fate change
Biomaterials are synthetic or natural materials that can
contact and integrate with biological system, but should
not be harmful to the patient when performing intended
functions [45]. A proper regulation of cell fate including
stem cell or reprogramming of mature cell is the key
issue in regenerative cell therapy. If reprogramming of
cell is not controlled sufficiently, the therapy might
cause teratoma, not treatment. There are numerous
biomaterials for determining cell fate or helping the
reprogramming process. Biomaterials can provide micro-
environments mimicking a specific cell niche, allowing
cells to differentiate into desired cell types [46]. The arti-
ficial stem cell niche can provide homing signals for
attracting and localizing stem cells [47]. It may work
similarly in direct reprogramming [48]. Classification of
these biomaterials is not simple because one biomaterial
can play multiple roles. Biomaterials can be classified in
terms of physical properties such as surface, mechanical,
electrical, and morphological properties. They can be clas-
sified in terms of the source such as natural, polymer, cer-
amic, and metals, or in terms of just shape such as 2D or
3D materials. In this review, we will describe the functions
of biomaterials in terms of physical aspects, biochemical
properties, and gene delivery (Fig. 1).
Biomaterials which regulate the stem cell fate can work
in direct reprogramming also in the same principle. So,
here some examples of biomaterials for stem cell differen-
tiation and further recent researches about biomaterials
for direct reprogramming will be described.
Table 2 Direct reprogramming into cardiomyocytes & hepatocytes
Species Starting cells Target cells Reprogramming factors Gene delivery Efficiency (%) Reference
Mouse Fibroblast neonatal (cardiac) iCM Gata4, Mef2c, Tbx5 Retrovirus 10~15 [30]
Mouse Fibroblast adult (cardiac) iCM Gata4, Mef2c, Tbx5 Retrovirus 12 [31]
Mouse Fibroblast adult (cardiac, tail-tip) iCM Gata4, Mef2c, tbx5, Hand2 Retrovirus 9.2 [32]
Mouse Fibroblast embryonic iCM Gata4, Tbx5, Baf60c CMV promoter <10 [33]
Mouse Fibroblast embryonic iCM Oct4, Sox2, Klf4, c-Myc Retrovirus - [34]
Mouse Fibroblast neonatal, Adult
(cardiac, tail-tip)
iCM miR-1,133,208,499 Lentivirus 1.5~7.8 [35]
Human Fibroblast fetal (heart), neonatal (skin) hiCM Gata4, Mef2c, Tbx5, Esrrg, Mesp1 Retrovirus 13 [36]
Human Fibroblast neonatal (foreskin), adult
(cardiac, dermal)
hiCM Gata4, Hand2, Tbx5, Myocardin, miR-1,133 Retrovirus 12~19 [37]
Mouse Fibroblast embryonic, adult (skin) iHep Hnf4a, Foxa1, Foxa2 or foxa3 Retrovirus 0.3 [40]
Mouse Fibroblast adult (tail-tip) iHep Gata4, Hnf1a, Foxa3, inactivation of p19Arf Lentivirus 20 [41]
Human Fibroblast fetal (limb), adult (dermal) hiHep Foxa3, Hnf1a, Hnf4a Lentivirus 10 [42]
Human Fibroblast newborn hiHep Oct4, Sox2, Klf4 Retrovirus - [43]
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Physical aspects
Physical properties of biomaterials for cell reprogramming
include mechanical strength (modulus) and surface topog-
raphies. First, the matrix elasticity of microenvironment
can regulate the cell fate. Generally, stiffer substrates in-
duce stiffer cells and softer substrates induce softer cells
[49]. In the same vein, soft matrix can stimulate the differ-
entiation of mesenchymal stem cell into neural like cells.
Moderate elasticity favors myogenic differentiation, and
rigid matrix promotes osteogenic differentiation [50]. A
pioneering work of Engler A et al. [51] demonstrated the
whole range differentiation of human mesenchymal stem
cell by modulating the matrix elasticity, including neuro-
genic differentiation from elastic modulus in 0.1–1 kPa
(brain), myogenic differentiation from elastic modulus in
8–17 kPa (muscle), and osteogenic differentiation from
elastic modulus in 25–40 kPa (osteoids). Cell morphology
also changed accordingly. So, the matrix properties can be
a potent differentiation cue for mesenchymal stem cells
[52, 53]. Similarly, physical signals like stiffness at the
interface between cell and substrate can be a potent regu-
lator for cell fate change. Soft hydrogel played an import-
ant role in making iPSCs via activation of mesenchymal to
epithelial transition [54].
Fiber diameter of substrates also could influence on
cell fate change [55, 56]. The fiber diameter of laminin
coated electrospun polyethersulfone mesh could regulate
the neural stem cell differentiation and proliferation.
Generally, as the fiber diameter decreased, the neural
stem cell proliferation rate increased. Cell morphology
in small fiber showed stretched and multi directional
shape, whereas the large fiber showed extended form
along a single axis due to the size restriction. Although
the main signals such as retinoic acid, fetal bovine
serum, growth factor, etc. were necessary for differenti-
ation or proliferation, the fiber diameter could increase
or decrease the efficiency distinctly. Similarly, the pores
of scaffold are also important cue. Levenger et al. [57]
made 3D porous biodegradable polymer scaffolds which
could influence the cell orientation, spreading and tissue
structures. 3D scaffolds itself could allow the recon-
struction and mimicking the complexity of the stem
cell niche. In addition, this group made pores in scaf-
fold to promote cell differentiation and homogeneity.
Poly(lactic-co-glycolic acid) (PLGA) for degradability
and poly(L-lactic acid) (PLLA) for mechanical stiffness
were blended, and 250–500 μm pores were made. This
scaffold helped the embryonic stem cell differentiation
into desired cell with each suitable growth factor such
as TGF-β for cartilage, Activin-A for liver like cells, and
RA for neuroectodermal like structures. Another group
made macroporous alginate scaffolds bearing cell adhe-
sion peptide RGD and heparin binding peptide [58].
Combination of these peptides could provide different
signaling processes in ECM-cell interactions and appro-
priate niche for cardiac stem cell behaviors.
Using a topographically patterned substrate without
using potentially harmful chemicals for determining the
lineage of stem cell is a safe and promising technique
[59]. Surface topography with micropatterned nanoridge
induced mesenchymal stem cell to acquire neuronal
characteristics [60]. Compared to fibroblast like morph-
ology of cells in smooth surface, stem cells became elon-
gated morphology in ridge patterned hydrogenated
amorphous carbon film. In other case, pattern of fibro-
nectin on a coverslip generated by microcontact printing
changed the differentiation tendency in accordance with
the position [61]. Without pattern, human mesenchymal
stem cell tends to differentiate into the osteogenic
lineage at the edge, and the cells in the center tends to
differentiate into adipocytes. However, cells cultured on
the patterned coverslip changed the location of osteo-
genic versus adipogenic differentiation. Nanotopography
also induced the changes in stem cell behaviors. Human
mesenchymal stem cell on nanopatterned substrate
showed lower integrin expression and FAK expression
levels than unpatterned substrate in the cases of both
soft (PDMS) and stiff (tissue culture polystyrene (TCPS))
substrate [62], meaning that nanotopographical cue has
a more significant influence than the substrate stiffness
Fig. 1 Classification of biomaterials strategies for cell fate
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on stem cell behaviors. Also, human mesenchymal stem
cells on PDMS with nanograting were differentiated into
neuronal like cells [63], proving that nanotopography
can make stem cells to differentiate into specific, non-
default pathways. In other study, hydrogen terminated
ultra nanocrystalline diamond films could promote
neural stem cell extension and protrusion [64]. There
are some reports of using substrate topography in direct
reprogramming. Direct reprogramming occurs in con-
junction with significant changes on epigenome includ-
ing the histone modification [65]. Leong et al. [20]
reported the effect of substrate topography on direct
reprogramming from fibroblasts to induced neurons.
They demonstrated that cell-topography interactions can
strongly influence the gene expression, neurite branch-
ing and outgrowth, and this shape and function deter-
mine the function of cells. In the course of neuronal
induction, the cytoskeleton rearrangement is a crucial
step. This cytoskeleton rearrangement responded to the
substrate topography and substrate stiffness [66]. In other
case, microtopography on cell adhesive substrate induced
the change of cell morphology responsible for the modula-
tion of epigenetic state [67]. Related to this result, micro-
or nano-scale topography on PDMS induced pronounced
changes in histone acetylation and methylation patterns
and significantly promoted a mesenchymal to epithelial
transition in adult fibroblasts [68, 69]. Specifically, the flat,
microgrooved, and nanogrooved substates worked differ-
ently in terms of cell alignment. One group compared this
by manufacturing the patterns using UV-assisted capillary
force lithography and analyzed the direct reprogramming
of somatic fibroblasts to neurons [70]. These passive topo-
graphical cues could offer a simple and effective possibility
to enhance the efficiency of cell reprogramming.
Microparticle is another example of biomaterials working
as a physical means. Microparticles have been widely used
for encapsulation and releasing diverse molecules in bioma-
terial experiments [71, 72]. M Andres et al. [73] made vari-
ous kinds of microparticles using various materials such as
PLGA, agarose, and gelatin. These microparticles were
stably integrated within aggregates of embryonic stem cells
in a dose dependent manner. The presence of microparti-
cles within stem cell aggregates could make stem cells to
adopt specific differentiated phenotypes according to fabri-
cated biomaterials. But, the efficiency of simple mixing of
microparticles and stem cells was very low, so the forced
aggregation was necessary. In almost all cases, maximal
production of desired differentiated cells was shown when
physical cue and chemical stimulus were applied together.
Also, specific ligand-receptor interactions of growth factor
or matrix molecules were more important than physical
cues for regulating cells. However, physical properties of
cell culture environments could also serve as a key factor in
determining the cellular function and fate [49].
Biochemical aspects
Biochemical cues such as extracellular matrix (ECM)
molecules, growth factors, and other signaling are essen-
tial to control the fate of cells. Especially, ECM compo-
nents and structures regulate cell fate through integrin
mediated activation and downstream signaling events
[74]. Collagen, laminin, fibronectin, and matrigel are
major ECM components. 3D collagen gel was used for
CNS stem cell differentiation into functional neuronal
circuits [75]. Because neuronal stem cells are anchorage
dependent and attach to a solid surface, those solid poly-
mer scaffolds are critical for neural tissue engineering.
However, neural cells do not adhere to synthetic hydro-
gel, so the modification of hydrogel with ECM proteins
such as collagen is necessary to provide relevant recog-
nition and biological cell adhesion. In contrast, stem
cells entrapped in biologically derived collagen hydrogel
could rapidly expand in serum free medium containing
bFGF, and showed the development to neurons, astro-
cytes, and oligodendrocytes. S Battista et al. [76] studied
the effect of matrix composition of 3D constructs on
embryonic stem cell differentiation. They made semi
interpenetrating polymer networks, composed of diverse
concentration of collagen, fibronectin, and laminin. In
different compositions, embryonic body development
and formation were different depending on the collagen
concentrations. A high concentration of collagen inhib-
ited cellular apoptosis so disrupted the embryonic body
formation, and fibronectin accelerated the endothelial
cell differentiation and vascularization. Laminin stimu-
lated cardiomyocyte differentiation from embryonic stem
cells. Collagen based hydrogel could also be applied in
direct reprogramming. Endothelial progenitor cells were
reprogrammed to smooth muscle cells, and this induced
smooth muscle cell assembled blood vessel structure in
a 3D dense collagen gel [77].
Fibrin is a large non globular protein formed by
polymerization of fibrinogen and thrombin [78]. An ideal
scaffold should have a relevant cell adhesion site and
signals for promoting cellular differentiation. fibrin scaf-
folds with various concentrations of fibrinogen, thrombin,
and aprotinin were characterized to make proper environ-
ments for neurogenesis [79]. They found out fibrinogen
concentration is more important than thrombin concen-
tration and higher thrombin concentration inhibits cell
migration inside the fibrin scaffold. Also, when cell seed-
ing density was high, more cell growth and differentiation
were observed. Additional aprotinin could control the rate
of gel degradation, so the optimal concentration of aproti-
nin was different depending on other compositions.
Another group used fibrin gel for embryonic stem cell
culture [80]. To retard the degradation of fibrin gel, fibrin
gel was modified with poly(ethylene glycol) (PEG) as a
secondary crosslinking method. This PEGylated fibrin
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culture increased the efficiency of cell expansion and
modulated the differentiation of embryonic stem cells.
PEG based hydrogel itself also has a potential for effective
cell fate reprogramming. PEG prevents unwanted adsorp-
tion of proteins, which can induce altering cell signaling
[81]. This property of PEG could potentially provide better
environment for cell reprogramming, and it nearly dou-
bled efficiency of making cardiomyocyte-like cells from
fibroblasts [82]. This result suggests the future direction
for developing a fully synthetic reprogramming micro-
environment by adding some adhesion molecules or
peptide to PEG based hydrogel. In this vein, one group
successfully induced vessel like structures using human
umbilical cord blood derived endothelial progenitor cells
(EPCs) which can be easily isolated from the peripheral
blood of adult or umbilical cord blood [83]. They designed
PEG conjugated to bioactive peptides that provide cell
adhesive and proteolytically degradable cues [84]. Com-
bining the differentiation potential of EPCs and the
characteristics of PEG hydrogel created the endogenous
matrices like environments and formed 3D microvessel
networks without supplemental angiogenic growth factors.
Some group showed the affinity and density of ligand-
receptor interactions at the biomaterial interface can be
modified to direct cell fates [85]. Fibronectin coated or
cycRGD presenting monolayer promoted osteogenesis. A
high density linRGD stimulated myogenesis whereas a low
density linRGD surface promoted neurogenesis. Also, high
affinity ligands enhanced osteogenesis while low affinity li-
gands primarily enhanced myogenesis at a high density
and neurogenesis at a low density. In this way, regulating
affinity and density of ligand could direct certain stem cell
differentiation. Furthermore, matrigel also useful as a cell
culture scaffold because it presents appropriate extracellu-
lar biochemical cues for stem cell differentiation [57, 86].
Growth factor is an important biochemical cue, too.
None of the growth factors can directly change cell fate
exclusively to one cell type, but each growth factor can
induce some lineage of cell fate. For example, Activin-A
or TGFβ1 mainly induces mesodermal cells, bFGF, BMP-
4, EGF, or retinoic acid induces ectodermal and mesoder-
mal differentiation, whereas NGF and HGF allow all three
embryonic germ layer differentiations [87]. Willerth et al.
[88] applied combination of growth factors on 3D fibrin
culture to determine their effects on embryonic stem cell
differentiation. They used five different growth factors and
found out the optimal concentration of each factors for
inducing neurons and oligodendrocytes. The notch signal-
ing pathway is also a key regulator of epithelial differenti-
ation. Jagged-1 which is notch ligand on the biomaterial
surface could regulate the stem cell differentiation [89].
Polystyrene or poly(hydroxyethyl methacrylate, HEMA)
bound notch ligand could upregulate both epithelial dif-
ferentiation and tight clustering. But, the presence of
Jagged-1 as a soluble form could not act as an antagonist.
So, it must be present as a bound form on other biomate-
rial surfaces. Other recent research suggested notch
signaling biomaterials function in a time specific activation
tunable manner [90]. This notch activation on embryonic
stem cell promoted the ectodermal gene expression, and
oriented Jagged-1 surface induced cardiac differentiation
from cardiovascular progenitor cells.
Recent studies reported that, instead of using the tran-
scription factors in direct reprogramming, the use of a
cocktail of small chemical molecules only could change
the cell fate. Small molecules are cell permeable, non-
immunogenic, and cost-effective [91]. Once small mole-
cules for direct reprogramming are selected throughout
the screening, the addition of the cocktail of small mole-
cules to the cell culture medium simply induced the
change of cell fate. For examples, Forskolin, ISX9,
CHIR99021, and SB431542 could induce functional neu-
rons from mouse fibroblasts [92]. Nan et al. [93] chem-
ically induced functional cardiomyocytes from human
fibroblasts by a combination of nine compounds.
Although the categories were divided into physical and
biochemical aspects in this article, the combination of
physical and biochemical cues such as regulating both
matrix stiffness and protein concentration on substrate
together [94, 95] in stem cell studies is an effective and
necessary strategy to change the fate of matured cells
more efficiently.
Biomaterials for gene delivery
Gene delivery is a widely used technique in cell related
research. It is an essential process for artificial changing
of cell fate or regulation of stem cell differentiation.
Before the development of new method of gene delivery,
viral vector had usually been used. But, this viral vector
has safety problems because viral vector may interfere
with the host sequence randomly. Therefore, the devel-
opment of safe gene delivery methods was necessary.
First alternative method developed was using nanopar-
ticles for gene delivery. For example, stimuli responsive
Hyaluronic acid (HA) -ss- Polyethylenimine (PEI) nano-
particles were developed as a non-viral gene vector [96].
Positively charged PEI can form nanocomplex with the
negative charge of DNA, and release it in the endosome,
but limited by its cytotoxicity. Many tissues have HA
receptors, and HA has polyanionic characteristic that
prevents the non-specific interaction between serum and
PEI, so HA can provide the stability and specificity of
the particle. Disulfide bond can give the enhanced release
of DNA release in the endosome. Similarly, Zhao et al.
[97] made Chitosan (CS) -ss-PEI nanoparticles for mediat-
ing osteogenic differentiation. In other case, magnetic
nanoparticles based vector system were applied for safe
and efficient gene delivery [98]. Magnetic nanoparticles
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covered by a biocompatible surface coating were func-
tionalized for delivery of therapeutic biomolecules such
as DNA, siRNA, or shRNA. Similarly, a micro/nano-
channel array based electroporation system was sug-
gested [99–101]. This is a single cell transfection system
which can deliver charged agents directly into the cytosol
electophoreitcally, so it is possible to control the precise
dosage. All of these transient gene expression using non-
viral vector can prevent the problems with overexpression
of genes and interference of viral vectors.
Other safe replacement method of viral vector medi-
ated gene delivery is using protein itself. But half-life of
protein is short, so it requires a large dose and high cost.
For example, D Kim et al. [102] used reprogramming
proteins fused with a cell penetrating peptide (CPP).
This method can avoid the genetic integration and im-
munogenic problems, but the efficiency was not good.
Generally, the efficiency of protein delivery into the cell
is very low because protein is macromolecule and hard
to penetrate cell membranes. Thus, there is a strong
need for biomaterials to increase the efficiency of intra-
cellular delivery of proteins. Qutachi et al. [103] deliv-
ered proteins into embryoinic body using PLGA
microparticles to control the differentiation of embry-
onic stem cells. Also, Bian et al. [104] made nanoparti-
cles, which can load growth factor proteins and combine
with hydrogel scaffolds. They could induce chondrogenic
lineage from mesenchymal stem cell by the protein
loaded microsphere scaffolds.
Lastly, 3D sphere culture is a promising method for
the safe and efficient gene deliver. Neural crest associ-
ated cells were induced by culturing fibroblasts with a
single factor FOXD3 without viral vector on the chitosan
substrate instead of TCPS [105]. Then, the cells grew in
a spheroid shape and held together the plasmid. Actu-
ally, the result showed a quite low transduction effi-
ciency, but a high viability (~100%) after transfection.
Similarly, 3D sphere induced neural progenitor like cells
from fibroblast were reported [106, 107]. Although the
repeated transduction is necessary due to the low trans-
duction efficiency, it can be free form the potential risk
of viral vector such as gene disruption, instability, and
tumor formation [108].
Still, there is no perfect biomaterial which fulfills all
requirements such as biocompatibility, biodegradability,
and high efficiency. However, one can select among
available materials and develop new materials for each
purpose based on previous studies.
Conclusions
In summary, direct reprogramming is a promising med-
ical technique for degenerative disease, incurable disease,
disease modeling, and drug development. Moreover, bio-
materials have the potential to empower this technique
to be more effective and stable. However, there are lots
of problems to overcome furthermore. In the aspect of
direct reprogramming, the way of interlinage conversion
is not established yet. Also, the safety is not proved in
longer term clinical trials, and the efficiency of direct re-
programming is still too low to produce enough amount
of cells for clinical treatment. Heterogeneity and imma-
turity of conversed cells also should be improved. In the
aspect of biomaterials, a fully synthetic reprogramming
microenvironment needs to be developed for quality
control and dealing with immunogenic problems. Also,
there is no clear evidence or report that biomaterials can
greatly improve the efficiency of direct reprogramming so
far. Overall, the more effective combination of biochem-
ical cue and physical cues for each direct reprogramming
process must be set into shape. And, the issues of time
consuming, low efficiency, and treatment convenience
should be considered together for clinical application.
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